The present invention relates to uses of proteins that bind MK2 to
modulate inflammation. More particularly, the invention relates to uses
of proteins that bind MK2 for treating condition that are related to
inflammation. The invention is useful for treating inflammatory
conditions, particularly those in which a decrease in inflammation would
be therapeutically beneficial.